Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 0 | 2,569 | 5,002 | 0 |
| Gross Profit | N/A | N/A | 2,569 | 5,002 | N/A |
| Operating Expenses | 5,938 | 8,869 | 4,955 | 20,862 | 5,676 |
| Operating Income | -5,938 | -8,869 | -2,386 | -15,860 | -5,676 |
| Other Income | 411 | 13,036 | -2,520 | -12,221 | 163 |
| Pre-tax Income | -5,527 | 4,167 | -4,906 | -28,081 | -5,513 |
| Net Income Continuous | -5,527 | 4,167 | -4,906 | -27,683 | -5,513 |
| Net Income | $-5,527 | $4,167 | $-4,906 | $-27,683 | $-5,513 |
| EPS Basic Total Ops | -0.59 | 0.51 | -3.22 | -21.50 | -2.14 |
| EPS Basic Continuous Ops | -0.59 | 0.51 | -3.22 | -21.50 | -2.14 |
| EPS Diluted Total Ops | -0.59 | -1.00 | -3.22 | -21.50 | -2.14 |
| EPS Diluted Continuous Ops | -0.59 | 0.49 | -3.22 | -21.50 | -2.14 |
| EPS Diluted Before Non-Recurring Items | -0.59 | -1.00 | -3.22 | N/A | -5.40 |
| EBITDA(a) | $-5,914 | $-8,869 | $-2,386 | $-15,516 | $-5,652 |